D
24.25
0.05 (0.21%)
| Previous Close | 24.20 |
| Open | 23.84 |
| Volume | 772,061 |
| Avg. Volume (3M) | 3,660,981 |
| Market Cap | 4,565,578,240 |
| Price / Earnings (TTM) | 20.38 |
| Price / Earnings (Forward) | 15.75 |
| Price / Sales | 7.85 |
| Price / Book | 4.69 |
| 52 Weeks Range | |
| Earnings Date | 13 May 2026 |
| Profit Margin | 39.13% |
| Operating Margin (TTM) | 35.32% |
| Diluted EPS (TTM) | 1.11 |
| Quarterly Revenue Growth (YOY) | 17.10% |
| Quarterly Earnings Growth (YOY) | 53.80% |
| Total Debt/Equity (MRQ) | 1.15% |
| Current Ratio (MRQ) | 6.97 |
| Operating Cash Flow (TTM) | 273.26 M |
| Levered Free Cash Flow (TTM) | 216.76 M |
| Return on Assets (TTM) | 12.31% |
| Return on Equity (TTM) | 22.50% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Doximity, Inc. | Bearish | Bearish |
AIStockmoo Score
1.5
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.50 |
|
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 2.24% |
| % Held by Institutions | 93.70% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 44.00 (RBC Capital, 81.44%) | Buy |
| Median | 34.00 (40.21%) | |
| Low | 33.00 (JP Morgan, 36.08%) | Hold |
| Average | 37.00 (52.58%) | |
| Total | 4 Buy, 3 Hold | |
| Avg. Price @ Call | 26.40 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 09 Mar 2026 | 44.00 (81.44%) | Buy | 25.49 |
| JP Morgan | 20 Feb 2026 | 33.00 (36.08%) | Hold | 25.55 |
| Piper Sandler | 20 Feb 2026 | 42.00 (73.20%) | Buy | 25.55 |
| Barclays | 11 Feb 2026 | 38.00 (56.70%) | Buy | 25.96 |
| Mizuho | 10 Feb 2026 | 34.00 (40.21%) | Hold | 27.24 |
| Canaccord Genuity | 09 Feb 2026 | 34.00 (40.21%) | Buy | 27.50 |
| Goldman Sachs | 09 Feb 2026 | 34.00 (40.21%) | Hold | 27.50 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |